Delivery Order SPE2DR25D1106-SPE2DR26FJD8X
- Not listed
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency awarded a delivery order valued at $16,503.90 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs. This delivery order, issued on July 19, 2025, with an ultimate completion date of July 21, 2025, operates under a firm fixed price structure with no set-aside designation. The award represents a competitive procurement action through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,501.30 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with performance in Conshohocken, Pennsylvania and completion by September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Provocholine Inhalation Solution in 18ml pack quantities, with a contract ceiling value of $9,767.18. This non-competitive delivery order represents a firm fixed price transaction with a completion date of October 24, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,597.80 to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18 mL pack. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a $2,039.43 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with performance in Conshohocken, Pennsylvania and completion scheduled for November 5, 2025. This is a firm fixed-price delivery order issued without set-aside designation, reflecting competitive award to the prime contractor based on open competition capabilities. The delivery order represents a child action under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml pack quantities, with a ceiling value of $2,210. The contract, awarded on September 8, 2025, represents a firm fixed-price delivery order with a completion deadline of September 9, 2025. This award utilizes no set-aside designation and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $1,809.68 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Provocholine inhalation solution in 18ML packs. This is a firm fixed price contract with an ultimate completion date of December 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for Provocholine inhalation solution in 18mL packs, with a ceiling value of $7,016.62 and a firm fixed price structure. The order is scheduled for completion by September 24, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJD8XDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18ML pack configuration, valued at $10,776.17 under a firm fixed-price contract type. The award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical supplier to the Defense Logistics Agency's medical supply chain, fulfilling federal procurement needs for military and veteran healthcare systems. The company's Provocholine delivery supports military medical operations by supplying this diagnostic inhalation agent, which is used in bronchial challenge testing to assess airway hyperresponsiveness. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen regularly executes competitively awarded delivery orders across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and medical supplies, demonstrating consistent capability to meet defense medical procurement requirements through the DLA's global pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 12/14/25 |